Prevalence of BRAF Mutation in Papillary Thyroid Cancer

Home Page
About
Submit A Journal
Submit A Conference
Submit Paper/Book
- Submit a Preprint
- Submit a Book
Contact

Dicle Tıp Dergisi
Volume:43 Issue:4
Prevalence of BRAF Mutation in Papillary Thyroid Cancer

Prevalence of BRAF Mutation in Papillary Thyroid Cancer

Authors : Shatha DMOUR, Ala’a AlMAAİTAH, Tunc EREN, Ozgur EKİNCİ, Orhan ALİMOGLU

Pages : 569-575

Doi:10.5798/diclemedj.0921.2015.01.0521

View : 56 | Download : 14

Publication Date : 2016-12-25

Article Type : Review Paper

Abstract :Objectives: Papillary thyroid cancer (PTC) is the most common endocrine malignancy and the most common genetic anomaly with PTC is the BRAF V600E mutation. This mutation is linked to many clinical and pathological features and may have a diagnostic and therapeutic role especially in the era of targeted therapy. The aim of this study is to review the prevalence of BRAF V600E mutation in PTC, its distribution according to the histological subtype and geographic area and its association with the age of patients, gender, subtype and recurrence of tumors. Methods: The Pubmed database was searched to look for articles about BRAF mutation in PTC. Outcomes of interest included prevalence, age, gender, country, subtype and recurrence. Results: The prevalence of BRAF V600E mutation in PTC was 47%, with noticeably higher prevalence in the eastern countries. The prevalence of BRAF V600E was also higher in the tall and classic subtypes and could be associated with worse prognosis and higher risk of recurrence. Conclusions: The BRAF mutation, which is more prevalent in the eastern countries, is determined to be an important molecular marker for PTC.
Keywords : Papillary thyroid cancer, BRAF mutation

ORIGINAL ARTICLE URL

* There may have been changes in the journal, article,conference, book, preprint etc. informations. Therefore, it would be appropriate to follow the information on the official page of the source. The information here is shared for informational purposes. IAD is not responsible for incorrect or missing information.